The Bertarelli Rare Cancers Fund supports advances in the detection, diagnosis, treatment, and prevention of rare cancers.
While all cancer diagnoses raise concerns and difficult questions for patients, their families, and their health care providers, rare cancers present additional challenges. Access to tumors and relevant samples for study is more limited, and commercial interest is lower because of decreased market size.
The Bertarelli Rare Cancers Fund, established in 2020 thanks to a generous gift from the Bertarelli Foundation, provides an important opportunity to develop a prominent role for rare cancer research in the Harvard community.
BRCF in the News: No Cancer Left Behind